International Parkinson and Movement Disorder Society
MDS Podcast
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.
Husk at besøge podcastens hjemmeside og støtte skaberen: www.movementdisorders.org
Forfatter
International Parkinson and Movement Disorder Society
Kategori
Podcastens hjemmeside
Seneste episode
21. okt. 2026
Hvor kan du lytte?
Podcasts i appen Replaio Radio Kommer snartPodcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts
Episoder
The role of young members in the peer review process 30.05.2022
For this episode of the special series focused on peer reviews, Dr. Daniel Di Luca speaks with Prof. Marcelo Merello about the role of young members and trainees in the peer review process.
Unmet needs of women with Parkinson's disease: Gaps and controversies 23.05.2022
Dr. Sarah Lidstone interviews Dr. Indu Subramanian about her recent paper, "Unmet needs of women with Parkinson's disease: Gaps and Controversies," in Movement Disorders . Read the article.
Approach to reviewing a review article 16.05.2022
For the sixth episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Christine Klein to discuss the approach to reviewing a review article.
Rasagiline in PD: Does it change disease progression? And how do we measure it? 09.05.2022
A recent trial showed no benefit of 1mg rasagiline versus placebo on 1-year progression in an early Parkinson's disease cohort. The investigators used a novel method to track disease progression with MRI, apart from usual clinical standards. Dr. David Vaillancourt shares the results of this trial recently published in the Movement Disorders Journal. Read the article.
How to review an original scientific article 02.05.2022
For this episode of our special series focused on the peer review process, Dr. Alana Kirby speaks with Dr. Tony Lang about how to approach reviewing an original scientific article.
Infectious agents as drivers of synucleinopathies? 25.04.2022
Dr. Tiago Outeiro interviews Dr. Morgane Linard about the recently published article, "Infectious Agents as Potential Drivers of α-Synucleinopathies." Read the Article. Journal CME will be available for this article until March 18, 2023.
Reviewing case reports and clinical series 18.04.2022
Dr. Daniel Di Luca discusses how to approach and review case reports and case series in movement disorders with Prof. Kailash Bhatia.
Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease? 11.04.2022
A discussion with Dr. Avner Thaler on the findings and implications of a study on the background of importance of GBA mutations and GCase activity in Parkinson's disease. Read the Article.
What are journal editors looking for in a good review? 04.04.2022
This is the third episode of the special series focused on the peer review process. In this episode, Dr. Alana Kirby speaks with Dr. Jon Stoessl about what journal editors are looking for in a good review. He provides practical tips for writing an effective peer review.
When to accept or decline an invitation to review 21.03.2022
For the second episode of the special series focused on the peer review process, Dr. Shweta Prasad speaks with Prof. Günther Deuschl about the crucial first part of the peer review process - identifying reviewers, and understanding when a reviewer should accept or decline an invitation to review.
Bilateral focused ultrasound thalamotomy for essential tremor, is it safe? 14.03.2022
Prof. Andres Lozano shares the results of the phase 2 clinical trial showing safety and feasibility of the staged bilateral MR-guided focus ultrasound thalamotomy in 10 patients. Read the article.
Overview and core components of the peer review process 07.03.2022
For the first episode of the special series focused on the peer review process, Dr. Daniel Di Luca speaks with Dr. Christopher Goetz about the importance and most important aspects of a peer review.
Neuropsychiatric features of punding and hobbyism in Parkinson's disease 15.02.2022
Dr. Hugo Morales discusses "Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease," by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice . Read the article.
Approach to neuroimaging in Parkinsonisms 17.01.2022
Dr. Sara Schaefer discusses with Professor Antonio Strafella and Dr. Cecilia Peralta their work from the MDS Neuroimaging Study Group published in Movement Disorders Clinical Practice on a "Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms." Read the article
Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology 13.12.2021
Dr. Günter Hoglinger discusses the article he recently published in the Movement Disorders journal on tau imaging in a cohort of corticobasal syndrome patients, along with amyloid PET and CSF analysis to differentiate the neuropathological entity underlying the clinical manifestations. Read the article
Variability of movement disorders: The influence of sensation 18.10.2021
Dr. Michele Matarazzo speaks with Prof. Maja Kojović about the paper awarded as 2021 best review article from the Movement Disorders journal, highlighting the impact on several factors on the variability of movement disorders. Read the article
The most impactful paper related to movement disorders therapy in the 20th century 18.10.2021
Dr. Sara Schaefer speaks with Dr. Stanley Fahn about the origins of levodopa therapy for Parkinson's disease in the 1960s, how that generated an explosion of interest and research in dopamine's role in movement disorders and beyond, and how it all led to the dawning of the movement disorders field, journal, society, and community that we are all part of today. Read the article
Swim for Parkinson: Swimming together to improve together 18.10.2021
The neurologists Dr. Francesca Morgante and Dr. Nicola Modugno and Cecilia Ferrari, a person with Parkinson's disease, share their experience swimming across the strait of Messina, highlighting the importance of physical activity in PD.
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target? 18.10.2021
Dr. Michele Matarazzo speaks with Prof. Ryosuke Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression. Read the article
An interview with Claudia Trenkwalder | Congress 2021 30.09.2021
Dr. Sara Schaefer discusses with Dr. Claudia Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients 01.09.2021
Dr. Sara Schaefer speaks with Dr. Anumantha Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease. Read the article
TikTok tics 01.08.2021
Dr. Sara Schaefer speaks with Dr. Caroline Olvera about trending videos of tics and other neurological syndromes on social media. Read the article
Cognitive and visuospatial abilities in dystonia 01.06.2021
Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. Read the article
Autophagy in levodopa-induced dyskinesia: A new potential therapeutic target 01.05.2021
Dr. Michele Matarazzo interviews Prof. Gilberto Fisone about the role of autophagy in levodopa-induced dyskinesia. Read the article
Electroconvulsive therapy in movement disorders 01.04.2021
Dr. Sara Schaefer discusses with Dr. Pedro Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. Read the article
Lignende podcasts
Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.